Detailed view for this entity.
“the management team is not very optimistic about sales and profits this year. They're forecasting 2026 adjusted sales growth of negative 5 to 13%.”
“it expects sales to decline by 9% at the midpoint for 2026. And this was very disappointing.”
“So let's look at valuation for Novo which is trading at a forward price to earnings of 19.”
“I recently updated my DCF calculation for Novo where I see the business worth $62 a share.”
“to update my buy, hold or sell rating, I think Novo stock is a buy at these valuations.”
“Novo is down today another 5.7% after being down 15% or so the day before when the earnings got released too early.”
“This outlook reflects a positive impact from a $4.2 billion reversal of sale rebate provision related to the 340B drug pricing program in the United States.”
“And so you can start to understand why the stock took a big hit.”
“Novo is back to almost yet the bottom prices that we've seen at the end of 2025. Now of course if you thought that you missed it...”